Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
johnson & johnson
achromatopsia
ajay royan
beta-thalassemia
bill cassidy
biotech
bluebird bio
boston blog main
boston top stories
clinical trials
deals
dna
events
fda
frederic moll
gene therapy
harvard pilgrim health care
health
hemophilia
life sciences
luxturna
mark warner
mathai mammen
medicaid
meiragtx
national blog main
national top stories
new york
new york blog main
new york top stories
novartis
patient affordability value and efficiency act
spark therapeutics
spinal muscular atrophy
startups
tc
techcrunch disrupt sf 2019
university of pennsylvania
value based agreements
x-linked retinitis pigmentosa
What
come
2
×
j
2
×
age
ajay
auris
bigger
biggest
billion
ceo
company
deal
disrupt
emerging
entrepreneurs
frederic
gave
gene
hansen
household
include
intuitive
inventors
investor
johnson
lead
manufacturer
medical
meiragtx
moll
moll’s
morning
old
past
publicly
robotic
royan
selling
signal
signals
successes
Language
Current search:
j
×
come
×
@techcrunch.com
4 years ago
After selling Auris for $3.4 billion to J&J, CEO Frederic Moll and lead investor Ajay Royan come to Disrupt
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
